OasisLMS

The Association of Cancer Cancer Centers (ACCC) has established the ACCC Community Oncology Research Institute (ACORI) to build on its existing mission to close the gap in cancer research through optimal oncology partnerships. As part of this mission, ACCC hosted the ACORI Call to Action Summit, a two-day virtual event that explored practical solutions to strengthen and diversify oncology clinical trials in communities across the country.

The Summit's interactive discussions focused around:

• The importance of expanding access to clinical trials for patients of all background—to ensure the highest quality care
• Strategies for engaging patients and their caregivers in shared decision-making around trial enrollment
• Case studies to demonstrate solutions for optimizing accrual and overcoming barriers to trial participation
• Tools and resources to support care teams, including budget forms, IRB templates, etc.
• How to incorporate the patient perspective into trial design: insights for trial sponsors

This Summit is open to the public. You do not need to be an ACCC member to view this webinar, but you will need to create an account in order to register. Please click the "Registration Instructions" tab for more details.

This Summit is part of the ACCC Community Oncology Research Institute and is supported by AbbVie, Amgen, AstraZeneca, Eisai, Genentech, Merck and Sanofi.

Day 1: Panel Discussions

Advancing Health Equity through Community Cancer Research
Sybil Green, JD, RPh, MHA, Diversity and Inclusion Officer, ASCO (Moderator)
Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance
Ysabel Duron, President/Executive Director, The Latino Cancer Institute
Linda Burhansstipanov, MSPH, DrPH, Founder, Native American Cancer Research Corporation; President, Native American Cancer Initiatives, Incorporated

Panel Conversation: Centering the Patient Perspective in Community Cancer Research
Jeanne Regnante, Chief Health Equity and Diversity Officer, LUNGevity Foundation (Moderator)
Shonta Chambers, MSW, Executive Vice President, Patient Advocate Foundation
Venus Ginés, MA, P/CHWI, CEO and Founder, Día de la Mujer Latina
Rodney Haring, PhD, MSW, Director, Center for Indigenous Cancer Research, Roswell Park Comprehensive Cancer Center

Fostering Readiness for Community Cancer Research
Nadine Barrett, PhD, MA, MS, Director, Office of Health Equity and Disparities, Duke Cancer Institute; Director, Duke Community Connections Core, Duke CTSA (Moderator)
Robert Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center
Nina Bickell, MD, MPH, Co-Lead, Cancer Prevention and Control, Tisch Cancer Institute
Randall A. Oyer, MD, Medical Director, Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health; ACORI Chair

Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development
Lola A. Fashoyin-Aje, MD, MPH, Deputy Division Director, FDA Oncology Center of Excellence
Jennie R. Crews, MD, MMM, FACP, Medical Director, SCCA Network & Community Sites, Seattle Cancer Care Alliance
Erin Williams MBA, Associate Director, SCCC Clinical Research Operations, University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center
Racquel Racadio, MPH, Senior Manager, Diversity and Representation in Clinical Research, Amgen

Day 2: Breakout Discussions

SU2C Special Session
Olajide Williams, MD, Founder and President, Hip Hop Public Health
Sung Poblete, PhD, RN, Chief Executive Officer, SU2C

Harnessing the Power of Community Partnerships to Improve Patient Accrual
Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance

Building Research Capacity to Strengthen Cancer Trials in the Community
Lola A. Fashoyin-Aje, MD, MPH, Deputy Division Director, FDA Oncology Center of Excellence

Incorporating the Patient Perspective into Trial Design
Carla Strom, MLA, Assistant Director, Operations, Wake Forest Baptist Health Comprehensive Cancer Center